LAMEA Neurostimulation Devices Market By Devices (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators and Other Devices) By Applications (Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy and Other Applications) By Country, Industry Analysis and Forecast, 2020 - 2026
The Latin America, Middle East and Africa Neurostimulation Devices Market would witness market growth of 13.5% CAGR during the forecast period (2020-2026).
Growth in the market for neurostimulation devices is due to increased use of neurostimulation devices in pain management and increased use of neurostimulation devices in developing economies. In addition, an increase in the incidence of chronic diseases is expected globally to boost the growth of the market for neurostimulation devices.
In addition, the increased demand for minimally invasive treatment, the uptake of technologically advanced products and the rise of aging demographics further accelerate market growth as they become more vulnerable to neurological diseases such as epilepsy, Parkinson's disease, Alzheimer's disease, and chronic pain. The major barriers in the growth of the market for neurostimulation devices are adverse effects such as allergic reactions and tingling or prickling of the skin related to the implantation of the neurostimulation system into the body and higher product costs. The availability of other treatment options such as drug therapies and surgeries however restrict the market growth.
Based on Devices, the market is segmented into Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators and Other Devices. Based on Applications, the market is segmented into Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy and Other Applications. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Nevro Corporation, Medtronic PLC, NeuroSigma, Inc., Integer Holdings Corporation, LivaNova PLC, NeuroPace, Inc., Neuronetics, Inc., and Synapse BioMedical, Inc.
Scope of the Study
Market Segmentation:
By Devices
Growth in the market for neurostimulation devices is due to increased use of neurostimulation devices in pain management and increased use of neurostimulation devices in developing economies. In addition, an increase in the incidence of chronic diseases is expected globally to boost the growth of the market for neurostimulation devices.
In addition, the increased demand for minimally invasive treatment, the uptake of technologically advanced products and the rise of aging demographics further accelerate market growth as they become more vulnerable to neurological diseases such as epilepsy, Parkinson's disease, Alzheimer's disease, and chronic pain. The major barriers in the growth of the market for neurostimulation devices are adverse effects such as allergic reactions and tingling or prickling of the skin related to the implantation of the neurostimulation system into the body and higher product costs. The availability of other treatment options such as drug therapies and surgeries however restrict the market growth.
Based on Devices, the market is segmented into Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators and Other Devices. Based on Applications, the market is segmented into Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy and Other Applications. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Nevro Corporation, Medtronic PLC, NeuroSigma, Inc., Integer Holdings Corporation, LivaNova PLC, NeuroPace, Inc., Neuronetics, Inc., and Synapse BioMedical, Inc.
Scope of the Study
Market Segmentation:
By Devices
- Spinal Cord Stimulators
- Deep Brain Stimulators
- Sacral Nerve Stimulators
- Vagus Nerve Stimulators and
- Other Devices
- Pain Management
- Hearing Loss
- Urinary Incontinence
- Parkinson's Disease
- Epilepsy and
- Other Applications
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
- Abbott Laboratories
- Boston Scientific Corporation
- Nevro Corporation
- Medtronic PLC
- NeuroSigma, Inc.
- Integer Holdings Corporation
- LivaNova PLC
- NeuroPace, Inc.
- Neuronetics, Inc.
- Synapse BioMedical, Inc.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Neurostimulation Devices Market, by Devices
1.4.2 LAMEA Neurostimulation Devices Market, by Applications
1.4.3 LAMEA Neurostimulation Devices Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.2.4 Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2016, Oct – 2020, May) Leading Players
CHAPTER 4. LAMEA NEUROSTIMULATION DEVICES MARKET BY DEVICES
4.1 LAMEA Spinal Cord Stimulators Market by Country
4.2 LAMEA Deep Brain Stimulators Market by Country
4.3 LAMEA Sacral Nerve Stimulators Market by Country
4.4 LAMEA Vagus Nerve Stimulators Market by Country
4.5 LAMEA Other Devices Market by Country
CHAPTER 5. LAMEA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS
5.1 LAMEA Pain Management Market by Country
5.2 LAMEA Hearing Loss Market by Country
5.3 LAMEA Urinary Incontinence Market by Country
5.4 LAMEA Parkinson's Disease Market by Country
5.5 LAMEA Epilepsy Market by Country
5.6 LAMEA Other Applications Market by Country
CHAPTER 6. LAMEA NEUROSTIMULATION DEVICES MARKET BY COUNTRY
6.1 Brazil Neurostimulation Devices Market
6.1.1 Brazil Neurostimulation Devices Market by Devices
6.1.2 Brazil Neurostimulation Devices Market by Applications
6.2 Argentina Neurostimulation Devices Market
6.2.1 Argentina Neurostimulation Devices Market by Devices
6.2.2 Argentina Neurostimulation Devices Market by Applications
6.3 UAE Neurostimulation Devices Market
6.3.1 UAE Neurostimulation Devices Market by Devices
6.3.2 UAE Neurostimulation Devices Market by Applications
6.4 Saudi Arabia Neurostimulation Devices Market
6.4.1 Saudi Arabia Neurostimulation Devices Market by Devices
6.4.2 Saudi Arabia Neurostimulation Devices Market by Applications
6.5 South Africa Neurostimulation Devices Market
6.5.1 South Africa Neurostimulation Devices Market by Devices
6.5.2 South Africa Neurostimulation Devices Market by Applications
6.6 Nigeria Neurostimulation Devices Market
6.6.1 Nigeria Neurostimulation Devices Market by Devices
6.6.2 Nigeria Neurostimulation Devices Market by Applications
6.7 Rest of LAMEA Neurostimulation Devices Market
6.7.1 Rest of LAMEA Neurostimulation Devices Market by Devices
6.7.2 Rest of LAMEA Neurostimulation Devices Market by Applications
CHAPTER 7. COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Approvals:
7.2 Boston Scientific Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.5.2 Product Launches and Product Expansions:
7.3 Nevro Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Approvals:
7.4 Medtronic PLC
7.4.1 Company overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Acquisition and Mergers:
7.4.5.3 Product Launches and Product Expansions:
7.4.5.4 Approvals:
7.5 NeuroSigma, Inc.
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 Integer Holdings Corporation
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 LivaNova PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Approvals:
7.7.5.2 Acquisition and Mergers:
7.8 NeuroPace, Inc.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Approvals:
7.8.2.2 Product Launches and Product Expansions:
7.9 Neuronetics, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Partnerships, Collaborations, and Agreements:
7.9.5.2 Approvals:
7.1 Synapse BioMedical, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Approvals:
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Neurostimulation Devices Market, by Devices
1.4.2 LAMEA Neurostimulation Devices Market, by Applications
1.4.3 LAMEA Neurostimulation Devices Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.2.4 Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2016, Oct – 2020, May) Leading Players
CHAPTER 4. LAMEA NEUROSTIMULATION DEVICES MARKET BY DEVICES
4.1 LAMEA Spinal Cord Stimulators Market by Country
4.2 LAMEA Deep Brain Stimulators Market by Country
4.3 LAMEA Sacral Nerve Stimulators Market by Country
4.4 LAMEA Vagus Nerve Stimulators Market by Country
4.5 LAMEA Other Devices Market by Country
CHAPTER 5. LAMEA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS
5.1 LAMEA Pain Management Market by Country
5.2 LAMEA Hearing Loss Market by Country
5.3 LAMEA Urinary Incontinence Market by Country
5.4 LAMEA Parkinson's Disease Market by Country
5.5 LAMEA Epilepsy Market by Country
5.6 LAMEA Other Applications Market by Country
CHAPTER 6. LAMEA NEUROSTIMULATION DEVICES MARKET BY COUNTRY
6.1 Brazil Neurostimulation Devices Market
6.1.1 Brazil Neurostimulation Devices Market by Devices
6.1.2 Brazil Neurostimulation Devices Market by Applications
6.2 Argentina Neurostimulation Devices Market
6.2.1 Argentina Neurostimulation Devices Market by Devices
6.2.2 Argentina Neurostimulation Devices Market by Applications
6.3 UAE Neurostimulation Devices Market
6.3.1 UAE Neurostimulation Devices Market by Devices
6.3.2 UAE Neurostimulation Devices Market by Applications
6.4 Saudi Arabia Neurostimulation Devices Market
6.4.1 Saudi Arabia Neurostimulation Devices Market by Devices
6.4.2 Saudi Arabia Neurostimulation Devices Market by Applications
6.5 South Africa Neurostimulation Devices Market
6.5.1 South Africa Neurostimulation Devices Market by Devices
6.5.2 South Africa Neurostimulation Devices Market by Applications
6.6 Nigeria Neurostimulation Devices Market
6.6.1 Nigeria Neurostimulation Devices Market by Devices
6.6.2 Nigeria Neurostimulation Devices Market by Applications
6.7 Rest of LAMEA Neurostimulation Devices Market
6.7.1 Rest of LAMEA Neurostimulation Devices Market by Devices
6.7.2 Rest of LAMEA Neurostimulation Devices Market by Applications
CHAPTER 7. COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Approvals:
7.2 Boston Scientific Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.5.2 Product Launches and Product Expansions:
7.3 Nevro Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Approvals:
7.4 Medtronic PLC
7.4.1 Company overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Acquisition and Mergers:
7.4.5.3 Product Launches and Product Expansions:
7.4.5.4 Approvals:
7.5 NeuroSigma, Inc.
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 Integer Holdings Corporation
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 LivaNova PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Approvals:
7.7.5.2 Acquisition and Mergers:
7.8 NeuroPace, Inc.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Approvals:
7.8.2.2 Product Launches and Product Expansions:
7.9 Neuronetics, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Partnerships, Collaborations, and Agreements:
7.9.5.2 Approvals:
7.1 Synapse BioMedical, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Approvals:
LIST OF TABLES
TABLE 1 LAMEA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 2 LAMEA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– NEUROSTIMULATION DEVICES MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– NEUROSTIMULATION DEVICES MARKET
TABLE 5 MERGERS & ACQUISITIONS – NEUROSTIMULATION DEVICES MARKET
TABLE 6 APPROVALS – NEUROSTIMULATION DEVICES MARKET
TABLE 7 LAMEA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 8 LAMEA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 9 LAMEA SPINAL CORD STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 LAMEA SPINAL CORD STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 LAMEA DEEP BRAIN STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 12 LAMEA DEEP BRAIN STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 13 LAMEA SACRAL NERVE STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 LAMEA SACRAL NERVE STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 LAMEA VAGUS NERVE STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 LAMEA VAGUS NERVE STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 LAMEA OTHER DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 LAMEA OTHER DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 LAMEA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 20 LAMEA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 21 LAMEA PAIN MANAGEMENT MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 LAMEA PAIN MANAGEMENT MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 LAMEA HEARING LOSS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 LAMEA HEARING LOSS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 LAMEA URINARY INCONTINENCE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 26 LAMEA URINARY INCONTINENCE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 27 LAMEA PARKINSON'S DISEASE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 28 LAMEA PARKINSON'S DISEASE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 29 LAMEA EPILEPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 30 LAMEA EPILEPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 31 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 32 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 33 LAMEA NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 34 LAMEA NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 35 BRAZIL NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 36 BRAZIL NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 37 BRAZIL NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 38 BRAZIL NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 39 BRAZIL NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 40 BRAZIL NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 41 ARGENTINA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 42 ARGENTINA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 43 ARGENTINA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 44 ARGENTINA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 45 ARGENTINA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 46 ARGENTINA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 47 UAE NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 48 UAE NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 49 UAE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 50 UAE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 51 UAE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 52 UAE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 53 SAUDI ARABIA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 54 SAUDI ARABIA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 55 SAUDI ARABIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 56 SAUDI ARABIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 57 SAUDI ARABIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 58 SAUDI ARABIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 59 SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 60 SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 61 SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 62 SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 63 SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 64 SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 65 NIGERIA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 66 NIGERIA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 67 NIGERIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 68 NIGERIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 69 NIGERIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 70 NIGERIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 71 REST OF LAMEA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 72 REST OF LAMEA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 73 REST OF LAMEA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 74 REST OF LAMEA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 75 REST OF LAMEA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 76 REST OF LAMEA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 77 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 78 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 79 KEY INFORMATION – NEVRO CORPORATION
TABLE 80 KEY INFORMATION – MEDTRONIC PLC
TABLE 81 KEY INFORMATION – NEUROSIGMA, INC.
TABLE 82 KEY INFORMATION – INTEGER HOLDINGS CORPORATION
TABLE 83 KEY INFORMATION – LIVANOVA PLC
TABLE 84 KEY INFORMATION – NEUROPACE, INC.
TABLE 85 KEY INFORMATION – NEURONETICS, INC.
TABLE 86 KEY INFORMATION – SYNAPSE BIOMEDICAL, INC.
TABLE 1 LAMEA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 2 LAMEA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– NEUROSTIMULATION DEVICES MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– NEUROSTIMULATION DEVICES MARKET
TABLE 5 MERGERS & ACQUISITIONS – NEUROSTIMULATION DEVICES MARKET
TABLE 6 APPROVALS – NEUROSTIMULATION DEVICES MARKET
TABLE 7 LAMEA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 8 LAMEA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 9 LAMEA SPINAL CORD STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 LAMEA SPINAL CORD STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 LAMEA DEEP BRAIN STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 12 LAMEA DEEP BRAIN STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 13 LAMEA SACRAL NERVE STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 LAMEA SACRAL NERVE STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 LAMEA VAGUS NERVE STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 LAMEA VAGUS NERVE STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 LAMEA OTHER DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 LAMEA OTHER DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 LAMEA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 20 LAMEA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 21 LAMEA PAIN MANAGEMENT MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 LAMEA PAIN MANAGEMENT MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 LAMEA HEARING LOSS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 LAMEA HEARING LOSS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 LAMEA URINARY INCONTINENCE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 26 LAMEA URINARY INCONTINENCE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 27 LAMEA PARKINSON'S DISEASE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 28 LAMEA PARKINSON'S DISEASE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 29 LAMEA EPILEPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 30 LAMEA EPILEPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 31 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 32 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 33 LAMEA NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 34 LAMEA NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 35 BRAZIL NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 36 BRAZIL NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 37 BRAZIL NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 38 BRAZIL NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 39 BRAZIL NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 40 BRAZIL NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 41 ARGENTINA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 42 ARGENTINA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 43 ARGENTINA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 44 ARGENTINA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 45 ARGENTINA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 46 ARGENTINA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 47 UAE NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 48 UAE NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 49 UAE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 50 UAE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 51 UAE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 52 UAE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 53 SAUDI ARABIA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 54 SAUDI ARABIA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 55 SAUDI ARABIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 56 SAUDI ARABIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 57 SAUDI ARABIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 58 SAUDI ARABIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 59 SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 60 SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 61 SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 62 SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 63 SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 64 SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 65 NIGERIA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 66 NIGERIA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 67 NIGERIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 68 NIGERIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 69 NIGERIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 70 NIGERIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 71 REST OF LAMEA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 72 REST OF LAMEA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 73 REST OF LAMEA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 74 REST OF LAMEA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 75 REST OF LAMEA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 76 REST OF LAMEA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 77 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 78 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 79 KEY INFORMATION – NEVRO CORPORATION
TABLE 80 KEY INFORMATION – MEDTRONIC PLC
TABLE 81 KEY INFORMATION – NEUROSIGMA, INC.
TABLE 82 KEY INFORMATION – INTEGER HOLDINGS CORPORATION
TABLE 83 KEY INFORMATION – LIVANOVA PLC
TABLE 84 KEY INFORMATION – NEUROPACE, INC.
TABLE 85 KEY INFORMATION – NEURONETICS, INC.
TABLE 86 KEY INFORMATION – SYNAPSE BIOMEDICAL, INC.
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2016, OCT – 2020, MAY) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: BOSTON SCIENTIFIC CORPORATION
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: MEDTRONIC PLC
FIG 7 RECENT STRATEGIES AND DEVELOPMENTS: LIVANOVA PLC
FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: NEUROPACE, INC.
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2016, OCT – 2020, MAY) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: BOSTON SCIENTIFIC CORPORATION
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: MEDTRONIC PLC
FIG 7 RECENT STRATEGIES AND DEVELOPMENTS: LIVANOVA PLC
FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: NEUROPACE, INC.
